| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1751-7141.2010.00072.X |
| P953 | full work available at URL | http://www.lejacq.com/articleDetail.cfm?pid=Prev%20Cardiol_13;4:186 |
| https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1751-7141.2010.00072.x | ||
| P698 | PubMed publication ID | 20860643 |
| P5875 | ResearchGate publication ID | 46402690 |
| P2093 | author name string | Farouk Mookadam | |
| Tahlil Warsame | |||
| Sherif E. Moustafa | |||
| Steven J. Lester | |||
| P2860 | cites work | Effect of ramipril and of rosiglitazone on carotid intima-media thickness in people with impaired glucose tolerance or impaired fasting glucose: STARR (STudy of Atherosclerosis with Ramipril and Rosiglitazone). | Q45992182 |
| The VYtorin on Carotid intima-media thickness and overall arterial rigidity (VYCTOR) study. | Q46011354 | ||
| Long-term effects of fenofibrate on carotid intima-media thickness and augmentation index in subjects with type 2 diabetes mellitus | Q46191136 | ||
| Comparison of effects of amlodipine and angiotensin receptor blockers on the intima-media thickness of carotid arterial wall (AAA study: amlodipine vs. ARB in atherosclerosis study). | Q46205952 | ||
| Long-term treatment with sulfhydryl angiotensin-converting enzyme inhibition reduces carotid intima-media thickening and improves the nitric oxide/oxidative stress pathways in newly diagnosed patients with mild to moderate primary hypertension | Q46229073 | ||
| Distribution and predictors of carotid intima-media thickness in young adults | Q46965402 | ||
| Carotid intima media thickness and plaques can predict the occurrence of ischemic cerebrovascular events. | Q49098182 | ||
| Predictive value of noninvasive measures of atherosclerosis for incident myocardial infarction: the Rotterdam Study. | Q51637221 | ||
| Prediction of risk for first age-related cardiovascular events in an elderly population: the incremental value of echocardiography | Q52008524 | ||
| Carotid artery intimal-medial thickness distribution in general populations as evaluated by B-mode ultrasound. ARIC Investigators | Q60692542 | ||
| Racial/Ethnic differences in hypertension and hypertension treatment and control in the multi-ethnic study of atherosclerosis (MESA) | Q60777283 | ||
| Ultrasonographically assessed carotid morphology and the risk of coronary heart disease | Q68000533 | ||
| Primary prevention of atherosclerotic cardiovascular disease: the high public burden of low individual risk | Q80033938 | ||
| Inhibitory effects of micronized fenofibrate on carotid atherosclerosis in patients with essential hypertension | Q80312309 | ||
| Carotid intima-media thickness and plaque characteristics as a risk factor for stroke in Japanese elderly men | Q80968106 | ||
| A meta-analysis of 17 randomized trials of a percutaneous coronary intervention-based strategy in patients with stable coronary artery disease | Q81931221 | ||
| Coronary Calcium as a Predictor of Coronary Events in Four Racial or Ethnic Groups | Q22250884 | ||
| Torcetrapib and carotid intima-media thickness in mixed dyslipidaemia (RADIANCE 2 study): a randomised, double-blind trial | Q28236480 | ||
| Simvastatin with or without ezetimibe in familial hypercholesterolemia | Q28274454 | ||
| Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study | Q28281870 | ||
| Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein | Q29547752 | ||
| General cardiovascular risk profile for use in primary care: the Framingham Heart Study | Q29614189 | ||
| Carotid intima-media thickening indicates a higher vascular risk across a wide age range: prospective data from the Carotid Atherosclerosis Progression Study (CAPS). | Q31024527 | ||
| Effect of statins alone versus statins plus ezetimibe on carotid atherosclerosis in type 2 diabetes: the SANDS (Stop Atherosclerosis in Native Diabetics Study) trial | Q33789084 | ||
| Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project | Q34534248 | ||
| ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundat | Q34604622 | ||
| Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for V | Q34748094 | ||
| Extended-release niacin or ezetimibe and carotid intima-media thickness. | Q35013008 | ||
| Comparison of intensive and low-dose atorvastatin therapy in the reduction of carotid intimal-medial thickness in patients with coronary heart disease | Q36014045 | ||
| Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2. | Q36738148 | ||
| Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group | Q36900139 | ||
| Coronary artery calcification compared with carotid intima-media thickness in the prediction of cardiovascular disease incidence: the Multi-Ethnic Study of Atherosclerosis (MESA). | Q36914416 | ||
| Carotid intima-media thickness and coronary artery calcium score as indications of subclinical atherosclerosis | Q37148438 | ||
| Effects of candesartan cilexetil on carotid remodeling in hypertensive diabetic patients: the MITEC study | Q37167569 | ||
| Clinical and subclinical cardiovascular disease and kidney function decline in the elderly | Q37228758 | ||
| High-dose B vitamin supplementation and progression of subclinical atherosclerosis: a randomized controlled trial | Q37239745 | ||
| C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men. | Q37363683 | ||
| Assessment of risk for developing coronary heart disease in asymptomatic individuals | Q37560554 | ||
| ACAT inhibition and progression of carotid atherosclerosis in patients with familial hypercholesterolemia: the CAPTIVATE randomized trial. | Q38383002 | ||
| Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial | Q38398357 | ||
| Cholesteryl ester transfer protein inhibitor torcetrapib and off-target toxicity: a pooled analysis of the rating atherosclerotic disease change by imaging with a new CETP inhibitor (RADIANCE) trials | Q40025523 | ||
| Incident coronary events and case fatality in relation to common carotid intima-media thickness | Q40429915 | ||
| Carotid and femoral ultrasound morphology screening and cardiovascular events in low risk subjects: a 10-year follow-up study (the CAFES-CAVE study(1)). | Q40703682 | ||
| Carotid wall thickness is predictive of incident clinical stroke: the Atherosclerosis Risk in Communities (ARIC) study | Q40774916 | ||
| Ultrasound B-mode imaging in observational studies of atherosclerotic progression | Q40881451 | ||
| Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. | Q40882910 | ||
| Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TEXCAPS): additional perspectives on tolerability of long-term treatment with lovastatin | Q43604509 | ||
| Intensive lipid lowering may reduce progression of carotid atherosclerosis within 12 months of treatment: the METEOR study | Q43646061 | ||
| Baseline values but not treatment-induced changes in carotid intima-media thickness predict incident cardiovascular events in treated hypertensive patients: findings in the European Lacidipine Study on Atherosclerosis (ELSA). | Q44062389 | ||
| Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis: principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind, long-term trial | Q44205741 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | atherosclerosis | Q12252367 |
| P304 | page(s) | 186-197 | |
| P577 | publication date | 2010-01-01 | |
| P1433 | published in | Preventive Cardiology | Q15751789 |
| P1476 | title | Subclinical atherosclerosis: evolving role of carotid intima-media thickness | |
| Subclinical Atherosclerosis: Evolving Role of Carotid Intima-Media Thickness | |||
| P478 | volume | 13 |
| Q36161792 | Association between Metabolic Components and Subclinical Atherosclerosis in Korean Adults |
| Q41208538 | Can the ankle brachial pressure index (ABPI) and carotis intima media thickness (CIMT) be new early stage markers of subclinical atherosclerosis in patients with rheumatoid arthritis? |
| Q37257848 | Carotid Artery Intima Media Thickness and HsCRP; Predictors for Atherosclerosis in Prediabetic Patients? |
| Q35085471 | Carotid intima-media thickness (CIMT) and carotid plaques in young Nepalese patients with angiographically documented coronary artery disease |
| Q37859746 | Carotid intima-media thickness and cardiovascular risk |
| Q41270485 | Evaluation of local carotid stiffness and inflammatory biomarkers in stable angina pectoris |
| Q49543901 | High blood pressure in the young: why should we care? |
| Q58581682 | Intima-media complex thickness and carotid atherosclerotic plaque formation in Lublin's population in the context of selected comorbidities |
| Q48568491 | Perirenal fat is related to carotid intima-media thickness in children. |
| Q33591543 | Preclinical atherosclerosis and metabolic syndrome increase cardio- and cerebrovascular events rate: a 20-year follow up |
| Q33972551 | Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey |
| Q64993036 | Relationship between Atherogenic Indices and Carotid Intima-Media Thickness in Prediabetes: A Cross-Sectional Study from Central India. |
| Q37330365 | miRNA-145 inhibits VSMC proliferation by targeting CD40 |
Search more.